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ABSTRACT
Background: Malaria and HIV infections are now 
endemic in Sub-Saharan Africa. The morbidity and 
mortality of  each infection is high in tropical Africa. 
Therefore, a co-infection of  both will be expected to 
present a gloomy picture. The aim of  this study was 
to determine the prevalence of  adult HIV 
seropositive patients with malaria antigen.
Methodology: 300 adults who were HIV 
seropositive were randomly selected and screened 
for malaria antigen, using the rapid diagnostic test 
technique on blood obtained through a finger prick, 
in the clinic.
Results: A total of  79 patients were positive, with a 
prevalence of  26.5%. 
Conclusion: The prevalence of  26.5% obtained is 
similar to that obtained in Jos, Nigeria (21%).There 
seems to be no difference in the prevalence rate of  
HIV infected patients with malaria and those that 
are seronegative for HIV.
Key Words: Malaria, HIV, seropositive, prevalence.
Correspondence: Dr. Wariso KT
of  note that Sub Saharan Africa is home to about 25million 
2  adults and children living with HIV/AIDS .
Some schools of  thought are of  the view that malaria is over 
diagnosed in Africa due to much emphasis placed on clinical 
5diagnosis with little or no laboratory component .
 There are presently five major species of  Plasmodia that attack 
man, leading to the malarial disease. These are Plasmodium 
falciparum, Plasmodium ovale, Plasmodium vivax, 
6Plasmodium malariae and Plasmodium knowlesi . Each specie 
differs widely in morphology, characteristics, geographical 
7distribution and clinical presentations . Malaria is endemic in 
Nigeria and other Sub-Saharan Africa due to the year round 
presence of  Plasmodium falciparum and the efficient 
transmission by its mosquito vectors (Anopheles gambiae and 
8Anopheles funestus) .
Owing to the overlapping distribution of  HIV and malaria, 
interactions between them are likely. However, studies have 
9-12shown conflicting reports . There has been controversy 
whether there is even any relationship between them. In 
Uganda, Muller and Moser, found no relationship between 
malaria and HIV infection and reported a prevalence of  18% 
13among pediatric and adult patients . On the other hand, 
Francine H, et al noted a higher prevalence rate of  25.6% of  
14malaria among HIV infected pregnant women in Uganda . 
Igbeneghu and others found a relationship between the two 
infections in a study from South West Nigeria. They noted that 
HIV infection increases the prevalence of  malaria.  The 
observation of  a marked reduction in the prevalence of  malaria 
parasitaemia and anemia in HIV infected pregnant women 
receiving cotrimoxazole with or without sulfadoxine-
pyrimethamine intermittent preventive therapy in pregnancy 
16has also been reported in Malawi . 
It has now been established that HIV affects the susceptibility 
to malaria, its clinical course and also impairs antibody 
17responses to malaria antigens . What is also known is that HIV 
1 infection affects malaria humoral immunity during 
18pregnancy, but data for non- pregnant females are lacking .
The gold standard test for malaria diagnosis is microscopic 
19examination of  Giemsa stained thick and thin blood smears . 
Although this method is a fast and inexpensive diagnostic 
procedure, it is largely dependent on the competence of  the 
microscopist. Achieving high sensitivity requires counting up 
to 100 microscopic fields which is time and labour intensive. 
Serological test have recently been established as alternative 
methods to conventional microscopy for the diagnosis of  
malaria. Immunochromatographic methods can detect antigen 
20and antibody reliably and can be quite specific for malaria . 
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INTRODUCTION
Malaria and HIV are among the most prevalent diseases in the 
world. It is estimated that about 350-400 million people have 
clinical episodes of  malaria annually and about 2.7 million 
1people die of  malaria annually .
It is also estimated that about 33 million people are living with 
HIV/AIDS globally with 2.7 million new cases and 2.1 million 
2deaths annually . The majority of  the new infections of  HIV 
occur in the adolescent group and young adults (15-24 years). It 
was estimated by UNAIDS that about 3.9% of  Nigerian adults 
3live with HIV/AIDS .
More than three quarters of  the death due to malaria occur in 
Sub Saharan Africa. This usually constitutes a drain of  
resources of  about $2 billion USD annually due to the effect it 
4has on the production cost of  health services . It is also worthy 
These rapid diagnostic test kits are said to be highly sensitive 
21and specific .  Their use may soon become an integral 
diagnostic method in Nigeria due to the ease of  testing, non 
reliance on microscopist skill, the non requirement of  
electricity supply which may not be readily available in contrast 
to microscopy in addition to, their added high sensitivity and 
21specificity for malaria .  In spite of  the more quantitative than 
qualitative estimation of  malaria associated with their use. 
Port Harcourt, the capital of  Rivers state, in Nigeria, also 
shares in the burden of  HIV/AIDS and malaria endemicity. 
However, there is no known data on the prevalence of  malaria 
in HIV seropositive adults living in the city. This research, 
which is a hospital based study, is aimed at determining the 
prevalence of  malaria antigenemia among HIV infected adults 
in Port Harcourt. 
METHODOLOGY
Three hundred (300) adults (200 females and 100 males) who 
were confirmed HIV seropositive patients, attending the 
HIV/AIDS clinic between August-September 2010, were 
randomly recruited on a consecutive basis following informed 
consent and screened for malaria using finger prick blood with 
the malaria Rapid Diagnostic Test (RDT) kit. 
The samples were randomly collected from patients that met 
the inclusion criteria between August and September, 2010, 
when the research was done. Those who participated are the 
patients that consented to being part of  the study and met other 
criteria of  the study design. The inclusion criteria were: (1) 
Adults who were HIV positive. (2) Those that have not had any 
antimalarial drugs three four weeks before presentation. (3) 
Those that were treatment naïve for HIV.
The exclusion criteria were: (1) Pregnant female HIV patients. 
(2) Those that were on any antimalarial drugs. (3) Children. (4) 
Those that are on any highly active anti retroviral therapy. 
The study was on adult males and females who attended the 
adult HIV clinic.  The pregnant women and children have their 
own HIV clinics. These patients were HIV treatment naïve 
+patients but other data such as CD4  count and individual ages 
where not considered, since they were not part of  the focus of  
the study.
 Rapid Diagnostic Test (RDT) kit was used. This is a 
Plasmodium Lactate Dehydrogenase enzyme (PLDH) 
containing substance. It is a 33kDa oxidoreductase and it is the 
last enzyme of  the glycolytic pathway essential for ATP 
generation and one of  the most abundant enzymes expressed 
by Plasmodium falciparum. PLDH does not persist in the 
blood but gets cleared about the same time as the parasites 
following successful treatment.
The test kits were quality controlled before usage. The 
sensitivity of  the test kit was stated to be 100% while the 
specificity was said to be 99% (by the manufacturer). The 
7validity was certified before usage .
The procedure uses 0.5ml of  whole blood of  the patient that is 
mixed with diluents in a well of  the cassette. The red blood cells 
are lysed by the diluents, releasing the malaria parasite antigens, 
which react with the antibody that was embedded on the well. 
A positive result gives two colored lines (for test and control); 
while a negative result gives a colored line. The result is read 
22after 15-30 minutes of  commencement of  the procedure .
All tests were done in the HIV/AIDS clinic after the patients 
had consented to be part of  the study at no cost to the patients. 
All positive cases were treated but the patients paid for their 
drugs. 
RESULT
The mean age of  the study was 24 years and the age range was 
from 18 years to 45 years. The age group distributions were: 18  
23 years (30), 24-28 years (120), 29-34 years (100), 35-39 years 
(30) and 40-45 years (20). The gender ratio was 2:1 in favour of  
females.
A total of  79 patients were positive for malaria parasite giving a 
rate of  26.5 %.
Out of  the 100 men that were screened 27 of  them were positive 
while 52 of  the 200 women were positive for malaria. 
 
The males had 27% positivity for malaria while the females 
have 26% positivity for malaria. There was no significant 
difference between males and females that were positive for 
malaria. (P <0.05).
DISCUSSION
The study had more females than males in a ratio of  (2:1). It 
was not surprising that more females were infected with 
malaria than males. 
The prevalence of  malaria among HIV infected patients who 
attended the HIV clinic between August and September 2010, 
at the University of  Port Harcourt Teaching Hospital was 
26.5%. This prevalence is comparable to what was reported by 
Francine H, et al with a prevalence of  25.6%, though obtained 
14in pregnant women in Uganda . The research excluded both 
pediatric and pregnant patients because, this group of  patients, 
receive their medications for HIV/AIDS from different clinics. 
Moreover, pregnancy may be an added immune suppressor. 
However, the prevalence differs with the work of  Addisie and 
23others in Debub University in Ethiopia , where they 
discovered that the prevalence of  HIV in malaria patients was 
4.2%. The higher prevalence obtained here may be due to the 
high sensitivity and specificity of  the rapid diagnostic test used. 
While Addisie and others used light microscopy of  stained 
slide films, the competence of  the microscopist and the 
antigenemic level of  malaria within the population sampled 
should explain the low prevalence in that study. 
24The work of  Uneke CJ  and his colleagues in Jos, Nigeria 
produced a prevalence of  21%. This is a more comparable 
result with this study than that of  Addisie and others. This 
similar prevalence obtained in Jos and Port Harcourt may be 
due to the fact that malarial endemicity is higher in Nigeria 
than in Ethiopia. It is  known that rapid diagnostic tests for 
malaria is not the gold standard but it is more convenient, easy 
to perform and the results obtained are comparable to those of  
microscopy if  the test is correctly done. One group of  patients 
that may vary the result is those with rheumatoid arthritis 
because they have rheumatoid factor in their blood which 
25could lead to false positive results . There were no reported 
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cases of  rheumatoid arthritis despite not being an exclusion 
criterion. Therefore, the prevalence from this study cannot be 
said to have been significantly increased by the effect of  
rheumatoid factor.  Finally, comparing the prevalence of  this 
study with other studies, it is similar to what have been reported 
in the general population, despite not having a control group of  
the unaffected population.
The prevalence of  malaria in HIV patients in males was slightly 
higher than that of  females (27% and 26%) respectively. 
CONCLUSION
The prevalence of  malaria in HIV infected patients who 
attended University of    Port Harcourt Teaching Hospital 
between the stated periods is 26.5%. This is similar to other 
reported studies done previously. 
This figure can be reduced further if  the malaria eradication 
program of  the Rivers state government is embraced by 
everyone within the state.
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